- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03675698
Radiological Images for Nasotracheal Tube Size Estimation (RINSE)
June 16, 2020 updated by: Amit Kumar Mittal, Rajiv Gandhi Cancer Institute & Research Center, India
Nasal Cavity Evaluation by CT Scan/ Magnetic Resonance Imaging to Access the Size of Nasotracheal Tube for Nasal Intubation
This trial is planned to estimate the size of nasotracheal tube (NTT) by calculating the diameter of both nasal cavity in radiological images of nose (CT scan/MRI) at the level below the inferior turbinate and floor of nose in coronal planes.
Smallest diameter will be considered to calculate the outer diameter of NTT, hence the size .
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
The planned trial will estimate the size of nasotracheal tube (NTT) by calculating the diameter of both nasal cavity in radiological images of nose (CT scan/MRI) at the level below the inferior turbinate and floor of nose at different levels in coronal planes.
Smallest diameter will be considered to calculate the outer diameter of NTT, hence the size.
The side of nasotracheal intubation will be decided after view the radiological images and the estimated size of NTT will be used.
Finally the ease of intubation and complications will be recorded.
Study Type
Observational
Enrollment (Actual)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Delhi
-
Rohini, Delhi, India, 110085
- Amit
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
oncosurgical patients with oral malignancies who required nasotracheal intubation for COMMANDO surgeries.
Description
Inclusion Criteria:
patients requiring nasal intubation for oromaxillofacial surgeries
Exclusion Criteria:
- 1. Midface instability
- Coagulopathy
- Suspected basilar skull fractures
- Large nasal polyps
- Suspected nasal foreign bodies
- Recent nasal surgery
- History of frequent episodes of epistaxis
- Prosthetic heart valves (increased risk of bacteremia during the insertion).
- Patients with deranged liver and renal functions.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Successful nasal intubation by selecting the correct size of nasotracheal tube estimated by measuring the diameter of nasal cavity in coronal section just below the inferior turbinate in radiological images.
Time Frame: After enrolment of the patient and before intubation
|
The diameter of both nasal cavities in coronal section of CT/MRI will be calculated at the level just below the inferior turbinate in anterior nasal cavity when inferior turbinates just appeared in the radiological image, than at level of maxillary sinus and just before cohanal opening in radiological images.
Minimal diameter will be used to estimate the size of nasotracheal tube before intubation.The images will also be used to select the side of nasal intubation after ruling out any nasal pathology like DNS, Spurs and marked turbinate hypretrophy.
|
After enrolment of the patient and before intubation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To find the complications associated with nasal intubations that were performed after assessing the radiological images.
Time Frame: At the time of intubation
|
The radiological images will be studied prior to intubation, the appropriate size of the nasotracheal tube will be selected and after ruling out any nasal pathology like DNS , spurs, concha bullosa side of nasal intubation will be decided.
|
At the time of intubation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 25, 2018
Primary Completion (Actual)
October 24, 2019
Study Completion (Actual)
March 10, 2020
Study Registration Dates
First Submitted
September 15, 2018
First Submitted That Met QC Criteria
September 17, 2018
First Posted (Actual)
September 18, 2018
Study Record Updates
Last Update Posted (Actual)
June 17, 2020
Last Update Submitted That Met QC Criteria
June 16, 2020
Last Verified
June 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- RES/SCM/30/2018/82
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nasotracheal Tube Passage Through Nasal Cavity
-
TC Erciyes UniversityCompletedComputed Tomography-guided Nasotracheal Intubation | The Space Where the Tube Will be Passed in the Internal Nasal Valve RegionTurkey
-
National Cancer Institute (NCI)Active, not recruitingMalignant Solid Neoplasm | Nasopharyngeal Carcinoma | Adenoid Cystic Carcinoma | Transitional Cell Carcinoma | Cholangiocarcinoma | Intrahepatic Cholangiocarcinoma | Chordoma | Gestational Trophoblastic Tumor | Pseudomyxoma Peritonei | Cervical Adenocarcinoma | Vaginal Adenocarcinoma | Vaginal Squamous Cell... and other conditionsUnited States, Guam
Clinical Trials on Nasotracheal Intubation
-
University Hospitals Coventry and Warwickshire...Not yet recruiting
-
Children's Hospital of PhiladelphiaBaylor College of Medicine; Children's Hospital Colorado; Seattle Children's... and other collaboratorsCompletedHypoxia | Intubation Complication | Intubation; Difficult or Failed | Hypoxemia | Anesthesia Intubation Complication | Pediatric HDUnited States
-
Seoul National University HospitalSMG-SNU Boramae Medical CenterNot yet recruitingNasotracheal Intubation
-
Seoul National University HospitalSMG-SNU Boramae Medical CenterRecruiting
-
Bezmialem Vakif UniversityCompleted
-
University of IowaCompleted
-
Universitätsklinikum Hamburg-EppendorfCompletedCritical Care | Tracheal Intubation MorbidityGermany
-
Wuhan Union Hospital, ChinaNot yet recruitingAirway Management | Intubation, Intratracheal
-
TC Erciyes UniversityCompletedComputed Tomography-guided Nasotracheal Intubation | The Space Where the Tube Will be Passed in the Internal Nasal Valve RegionTurkey
-
Taipei Veterans General Hospital, TaiwanCompletedDysphagia | Dysphonia | Pressure InjuryTaiwan